Literature DB >> 29274143

Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision.

Kimberley S Samkoe1,2,3, Brent D Bates2, Niki N Tselepidakis3, Alisha V DSouza3, Jason R Gunn3, Dipak B Ramkumar4, Keith D Paulsen2,3, Brian W Pogue2,3, Eric R Henderson4,5.   

Abstract

Wide local excision (WLE) of tumors with negative margins remains a challenge because surgeons cannot directly visualize the mass. Fluorescence-guided surgery (FGS) may improve surgical accuracy; however, conventional methods with direct surface tumor visualization are not immediately applicable, and properties of tissues surrounding the cancer must be considered. We developed a phantom model for sarcoma resection with the near-infrared fluorophore IRDye 800CW and used it to iteratively define the properties of connective tissues that typically surround sarcoma tumors. We then tested the ability of a blinded surgeon to resect fluorescent tumor-simulating inclusions with ∼1-cm margins using predetermined target fluorescence intensities and a Solaris open-air fluorescence imaging system. In connective tissue-simulating phantoms, fluorescence intensity decreased with increasing blood concentration and increased with increasing intralipid concentrations. Fluorescent inclusions could be resolved at ≥1-cm depth in all inclusion concentrations and sizes tested. When inclusion depth was held constant, fluorescence intensity decreased with decreasing volume. Using targeted fluorescence intensities, a blinded surgeon was able to successfully excise inclusions with ∼1-cm margins from fat- and muscle-simulating phantoms with inclusion-to-background contrast ratios as low as 2∶1. Indirect, subsurface FGS is a promising tool for surgical resection of cancers requiring WLE. (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE).

Entities:  

Keywords:  ABY-029; image-guided surgery; indirect visualization; molecular targeting; near-infrared fluorescence; sarcoma

Mesh:

Year:  2017        PMID: 29274143      PMCID: PMC5741805          DOI: 10.1117/1.JBO.22.12.121613

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  51 in total

1.  Fluorescence imaging in vivo: raster scanned point-source imaging provides more accurate quantification than broad beam geometries.

Authors:  Brian W Pogue; Summer L Gibbs; Bin Chen; Mark Savellano
Journal:  Technol Cancer Res Treat       Date:  2004-02

2.  Light scattering in Intralipid-10% in the wavelength range of 400-1100 nm.

Authors:  H J van Staveren; C J Moes; J van Marie; S A Prahl; M J van Gemert
Journal:  Appl Opt       Date:  1991-11-01       Impact factor: 1.980

3.  Imaging breast adipose and fibroglandular tissue molecular signatures by using hybrid MRI-guided near-infrared spectral tomography.

Authors:  Ben Brooksby; Brian W Pogue; Shudong Jiang; Hamid Dehghani; Subhadra Srinivasan; Christine Kogel; Tor D Tosteson; John Weaver; Steven P Poplack; Keith D Paulsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

4.  Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas.

Authors:  Alexander Stojadinovic; Denis H Y Leung; Axel Hoos; David P Jaques; Jonathan J Lewis; Murray F Brennan
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

6.  Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.

Authors:  Osamu Sato; Takuro Wada; Akira Kawai; Umio Yamaguchi; Atsushi Makimoto; Yasuo Kokai; Toshihiko Yamashita; Hirokazu Chuman; Yasuo Beppu; Yoichi Tani; Tadashi Hasegawa
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

7.  Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model.

Authors:  John P Gleysteen; J Robert Newman; David Chhieng; Andra Frost; Kurt R Zinn; Eben L Rosenthal
Journal:  Head Neck       Date:  2008-06       Impact factor: 3.147

8.  Expression of HER1/EGFR protein in human soft tissue sarcomas.

Authors:  J-L Yang; M T Hannan; P J Russell; P J Crowe
Journal:  Eur J Surg Oncol       Date:  2006-03-07       Impact factor: 4.424

9.  Expression and significance of EGFR in malignant peripheral nerve sheath tumor.

Authors:  Daniel Keizman; Josephine Issakov; Isaac Meller; Natalie Maimon; Natalie Meimon; Maya Ish-Shalom; Osnat Sher; Ofer Merimsky
Journal:  J Neurooncol       Date:  2009-03-28       Impact factor: 4.130

10.  Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats.

Authors:  Milton V Marshall; Daniel Draney; Eva M Sevick-Muraca; D Michael Olive
Journal:  Mol Imaging Biol       Date:  2010-12       Impact factor: 3.488

View more
  10 in total

1.  Correcting for targeted and control agent signal differences in paired-agent molecular imaging of cancer cell-surface receptors.

Authors:  Negar Sadeghipour; Scott C Davis; Kenneth M Tichauer
Journal:  J Biomed Opt       Date:  2018-06       Impact factor: 3.170

2.  Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma.

Authors:  Stan van Keulen; Nynke S van den Berg; Naoki Nishio; Andrew Birkeland; Quan Zhou; Guolan Lu; Han-Wei Wang; Lyle Middendorf; Tymour Forouzanfar; Brock A Martin; A Dimitrios Colevas; Eben L Rosenthal
Journal:  Oral Oncol       Date:  2018-11-21       Impact factor: 5.337

3.  Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.

Authors:  Kimberley S Samkoe; Hira Shahzad Sardar; Jason Gunn; Joachim Feldwisch; Konstantinos Linos; Eric Henderson; Brian Pogue; Keith Paulsen
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-05-22

4.  Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection.

Authors:  Kimberley S Samkoe; Hira S Sardar; Brent D Bates; Niki N Tselepidakis; Jason R Gunn; Kevin A Hoffer-Hawlik; Joachim Feldwisch; Brian W Pogue; Keith D Paulsen; Eric R Henderson
Journal:  J Surg Oncol       Date:  2019-04-04       Impact factor: 3.454

5.  Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.

Authors:  Cheng Wang; Xiaochun Xu; Sassan Hodge; Eunice Y Chen; P Jack Hoopes; Kenneth M Tichauer; Kimberley S Samkoe
Journal:  Mol Imaging Biol       Date:  2021-10-12       Impact factor: 3.484

6.  Comparison of detection sensitivity of near infrared (NIR) surgical imaging systems using a connective tissue phantom model.

Authors:  Hira Shahzad Sardar; Qais Zai; Jason Gunn; Brian Pogue; Keith Paulsen; Kimberley Samkoe; Eric Henderson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-03-07

7.  Correcting Cherenkov light attenuation in tissue using spatial frequency domain imaging for quantitative surface dosimetry during whole breast radiation therapy.

Authors:  Rachael Hachadorian; Petr Bruza; Michael Jermyn; Amaan Mazhar; David Cuccia; Lesley Jarvis; David Gladstone; Brian Pogue
Journal:  J Biomed Opt       Date:  2018-11       Impact factor: 3.170

8.  Validation of a surgical training model containing indocyanine green for near-infrared fluorescence imaging.

Authors:  Naoki Nishio; Sohei Mitani; Kayo Sakamoto; Gaku Morimoto; Sayaka Yokoi; Mayu Shigeyama; Akihisa Wada; Nobuaki Mukoyama; Eben L Rosenthal; Michihiko Sone
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-08

Review 9.  Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents.

Authors:  Servando Hernandez Vargas; Christie Lin; Hop S Tran Cao; Naruhiko Ikoma; Solmaz AghaAmiri; Sukhen C Ghosh; Adam J Uselmann; Ali Azhdarinia
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

10.  EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.

Authors:  Quan Zhou; Nynke S van den Berg; Eben L Rosenthal; Michael Iv; Michael Zhang; Johana C M Vega Leonel; Shannon Walters; Naoki Nishio; Monica Granucci; Roan Raymundo; Grace Yi; Hannes Vogel; Romain Cayrol; Yu-Jin Lee; Guolan Lu; Marisa Hom; Wenying Kang; Melanie Hayden Gephart; Larry Recht; Seema Nagpal; Reena Thomas; Chirag Patel; Gerald A Grant; Gordon Li
Journal:  Theranostics       Date:  2021-05-21       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.